Cytochrome P450 CYP3A in human renal cell cancer
1999
Cytochrome P450 CYP3A in Renal Cell Cancer
publication
Author Information
Author(s): Murray G I, McFadyen M C E, Mitchell R T, Cheung Y-L, Kerr A C, Melvin W T
Primary Institution: University of Aberdeen
Hypothesis
The study investigates the presence and localization of CYP3A in renal cell cancer and normal kidney tissue.
Conclusion
CYP3A is expressed in both renal cell cancer and normal kidney, which may influence the metabolism of chemotherapy drugs.
Supporting Evidence
- CYP3A was consistently expressed in both renal cell cancer and normal kidney.
- In renal cell cancer, CYP3A was localized to tumor cells.
- CYP3A4 mRNA was present in 65% of tumors and 90% of normal samples.
Takeaway
This study found that a protein called CYP3A is present in kidney cancer cells and normal kidney cells, which might help in how cancer treatments work.
Methodology
The study used immunohistochemistry, immunoblotting, and RT-PCR to analyze CYP3A expression.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website